| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.31 | 8e-10 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |